Active
Small Business
Overview
- Legal name
- METACLIPSE THERAPEUTICS CORP
- Registered location
- ATLANTA, GA, USA
- Website
- Company website ↗
- Primary NAICS
- 541713 — Research and Development in Nanotechnology
- Latest award activity
- Aug 11, 2026
Read company summary
METACLIPSE THERAPEUTICS CORP is associated with UEI MU6JZBDZR8X1 and CAGE 6BYQ1 in public federal records. AcornBids currently links 1 prime award totaling $300.0K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Nanotechnology. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541713 (Research and Development in Nanotechnology). Its public SAM.gov registration lists ATLANTA, GA, USA.
At a glance
Lifetime prime obligations$300.0K
Prime awards1
Awards with future end dates1
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- METACLIPSE THERAPEUTICS CORP
- UEI
- MU6JZBDZR8X1
- CAGE
- 6BYQ1
- Registered address
- 3342 INTERNATIONAL PARK DR SE, ATLANTA, GA, 30316, USA
- Registration status
- Active
- Primary NAICS
- 541713 — Research and Development in Nanotechnology
- SAM activation
- Jun 11, 2026
- Initial registration
- Mar 21, 2011
- Entity start
- Jan 11, 2010
- SAM updated
- Jun 11, 2026
- Registration expires
- Jun 9, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N91025C00038SBIR CONCEPT AWARD FOR DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS | Department of Health and Human Services | $300.0K | Sep 5, 2025 | Jun 4, 2027 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Jun 11, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Mar 21, 2011 |
| Entity start | Jan 11, 2010 |
Registration classifications: Self Certified Small Disadvantaged Business, Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 541713 — Research and Development in Nanotechnology | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| SHAKER REDDY | Government business | Contact method not published | SAM registration | Not available |
| PERIASAMY SELVARAJ | Alternate government business | Contact method not published | SAM registration | Not available |
| SHAKER REDDY | Electronic business | Contact method not published | SAM registration | Not available |
| PERIASAMY SELVARAJ | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541713 — Research and Development in Nanotechnology
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
158 awards
65 awards
55 awards
48 awards
47 awards
About METACLIPSE THERAPEUTICS CORP
What products and services appear in its federal awards?
Recorded award industries: 541713 — Research and Development in Nanotechnology.
Recorded products and services: AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH.
Examples from recent award records:
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
3342 INTERNATIONAL PARK DR SE, ATLANTA, Georgia 30316, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
541713 — Research and Development in Nanotechnology.
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit